REN and atherosclerosis: Using the comprehensive data set of the 300-OB study, we here provide a detailed assessment of the association of circulating aldosterone and renin levels with inflammation, metabolic dysregulation, and atherosclerosis in the obese to address the hypothesis that RAAS activation—in particular aldosterone—contributes to metabolic dysregulation and atherosclerosis development in these patients and unravel the underlying mechanisms.